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BCL-2 Bak -/-MEFs were treated with the indicated dose of ABT-737 and cell death assessed by PI uptake after 24 h. Data is mean +/-SEM of 3 independent experiments. (d) Lentiviral transduction of expression constructs for Cas9 (mCherry) and sgRNA library (BFP) . (e) Reduced sgRNA representation following treatment with ABT-737. In untreated control cells, almost 60,000 sgRNA were detected. Gene ontology analysis confirmed that those sgRNA that were not detected were significantly enriched for essential house-keeping genes (data not shown 
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Chin, van Delft_Supp. Fig. 2 Vdac2 CRISPR/Cas9 editing Chin_Supp. GACTAGCGATGTGTATCCCTCCACCCTAT 
Chin_Supp. Fig. 7 Supplementary Fig. 7 . Vdac2 -/-hepatocytes have mitochondria that are resistant to MOM permeabilization and exhibit hydropic swelling. (a) BAK dissociates from VDAC2 complex during platelet apoptosis. Platelets isolated from wild-type mice were incubated with ABT-737 (1.6 µM) for 90 minutes prior to BN-PAGE and immunoblotting. (b) Lethally-irradiated Ly5.1 Rag -/-mice were reconstituted with bone marrow-derived hematopoietic precursors from Vdac2 -/-or age-matched wild-type (Ly5.2) mice. Mice were sacrificed 8 weeks post-reconstitution and the proportion of Ly5.2 + donor cells in the thymus and spleen were quantified. N=2-4 recipient mice. (c) Thymocytes and splenocytes isolated from Vdac2 -/-or age-matched C57BL/6 mice were cultured in the absence of fetal calf serum (serum withdrawal) or in the presence of PMA (100 mg/ml), dexamethasone (30 nM) or ionomycin (1 mg/ml) prior to the quantitation of viable cells (AnnexinV 
